Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

N/ATerminatedNCT01987193

University of Florida3 enrolled

Overview

The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Brain Cancer Prostate Cancer Lung Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Solid tumors in the intracranial, thoracic, or pelvic regions. Exclusion Criteria: N/A \-

Locations (1)

University of Florida Proton Therapy Institute

Jacksonville, Florida, United States

Outcomes

Primary Outcomes

Patients with hypoxic tumor identified by tumor blood flow measurement.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.